Showing results (71-80 of 152) with videos related to
Sort By:
Pageof 16
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.Lupus Science & Medicine|May 4, 2026
Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupusJyoti Bakshi, Rym Abida, Sara Croca, et al.Arthritis Research & Therapy|April 19, 2015
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assaysBahar Artim-Esen, Charis Pericleous, Ian Mackie, et al.Arthritis Research & Therapy|April 19, 2015
IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational studySara Croca, Paul Bassett, Sharon Chambers, et al.The Journal of Rheumatology|March 1, 2003
Defining Clinical Improvement in Adult and Juvenile MyositisLisa G Rider, Edward H Giannini, Michael Harris-Love, et al.Kidney International Reports|January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis CohortsValentina Querin, Natasha Jordan, David P D'Cruz, et al.Revista Clinica Espanola|April 26, 2024
Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort studyCandido Muñoz Muñoz, Filipa Farinha, Thomas McDonnell, et al.Lupus Science & Medicine|November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulinJessica J Manson, Kevin Mills, Elizabeth Jury, et al.Molecular Immunology|September 9, 2011
Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodiesCharis Pericleous, Jennifer Miles, Diego Esposito, et al.Rheumatology (Oxford, England)|November 26, 2009
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyDavid Isenberg, Gerald B Appel, Gabriel Contreras, et al.Pageof 16